The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS SUMMARY: Wizz Air Chair Buys GBP700,000 In Shares

Wed, 18th Mar 2020 18:09

(Alliance News) - The follow is a round-up of share dealings by UK company directors and managers announced on Tuesday and Wednesday and not separately reported by Alliance News:

----------

Wizz Air Holdings PLC - Chair William Franke buys 30,000 shares at GBP23.55, worth GBP706,500, on Tuesday.

----------

Witan Investment Trust PLC - Chair Henry Henderson buys 250,000 shares at 147.78p, worth GBP369,450, on Tuesday.

----------

IWG PLC - CEO Mark Dixon buys 241,924 shares at GBP1.4465 average, worth GBP349,943, on Tuesday. Dixon had bought buys 2.0 million shares at average GBP1.512, worth GBP3.0 million, on Monday. Non-Executive Director Francois Pauly buys 25,000 shares at average GBP1.15, worth GBP28,750, on Wednesday.

----------

Coca-Cola European Partners PLC - Chief Strategy Officer Victor Rufart buys 5,000 shares at EUR29.45, worth EUR147,250, on Wednesday.

----------

Accesso Technology Group PLC - CEO Steve Brown buys 151,000 shares at 137.8p, worth GBP208,050, on Wednesday. Now holds 665,774 shares, 2.4%. Accesso on Wednesday said it swung to a loss for 2019 due to a large impairment charge and lower-than-anticipated new customer wins. The company, which provides software solutions to the leisure and entertainment markets, said that coronavirus was impacting its transactional-based revenue.

----------

Cineworld Group PLC - Non-Executive Director Eric Senat buys 423,410 shares at GBP0.235, worth GBP99,501, on Wednesday.

----------

Finsbury Growth & Income Trust PLC - Chair Anthony Townsend buys 15,500 shares at 637.00p, worth GBP98,735, on Wednesday.

----------

Tritax Big Box REIT PLC - Non-Executive Director Aubrey Adams buys 50,000 shares at 93.6p, worth GBP46,800, on Tuesday.

----------

Argentex Group PLC - Non-Executive Director Henry Beckwith buys 37,832 shares at 107p to 112p, worth GBP41,209, on Monday and Tuesday.

----------

Oncimmune Holdings PLC - Non-Executive Vice Chair Geoffrey Hamilton-Fairley buys 25,000 shares at GBP0.41, worth GBP10,250, on Wednesday. Now holds 3.2 million shares, 5.1%.

----------

EMIS Group PLC - CEO Andrew Thorburn buys 10,000 shares at average 767.34, worth GBP76,734, on Wednesday. Emis on Wednesday said annual profit declined slightly as a result of reorganisation costs, which were not incurred the year before. The healthcare software and services firm reported a GBP27.1 million pretax profit for 2019, a 3.6% decline from the previous year's GBP28.1 million profit.

----------

Trinity Exploration & Production PLC - Leadership buy 1.5 million shares, worth about GBP90,000, on Tuesday. Philippa Dingwall, wife of Executive Chair Bruce Dingwall, buys 508,474 shares at GBP0.059. Non-Executive Director Angus Winther buys 830,000 shares at GBP0.06. CFO Jeremy Bridglalsingh buys 203,320 at GBP0.0565. Bruce Dingwall is now interested in 14.0 million shares, 3.6% of total, Winther in 30.9 million or 8.1%, and Bridglalsingh in 410,383, 0.1%.

----------

4D Pharma PLC - Chair David Norwood buys 100,000 shares at 28p, worth GBP28,000, on Tuesday. Now holds 8.6 million shares, 7.8% of total.

----------

Checkit PLC - Non-Executive Director John Wilson buys 100,729 shares at 24.92p, worth GBP25,102, on Wednesday. Now holds 789,259 shares, 1.3% of total.

----------

Henderson International Income Trust PLC - Director Simon Jeffreys buys 21,180 shares at 118.03p, and Elizabeth Jeffreys buys 16,946 shares at 118.02, together worth about GBP45,000, on Tuesday.

----------

Barclays PLC - Non-Executive Director Crawford Gillies buys 60,000 shares at GBP0.8287, worth GBP49,722, on Tuesday.

----------

GB Group PLC - Non-Executive Chair David Rasche buys 19,100 shares at average 518.86p, worth GBP99,102, on Monday and Tuesday. Now holds 744,333 shares, 0.4% of total.

----------

Volution Group PLC - Non-Executive Director Tony Reading buys 10,000 shares at 135.6p, worth GBP13,560, on Wednesday. Now holds 100,000 shares, 0.1% of total.

----------

Hipgnosis Songs Fund Ltd - Director Simon Holden buys 20,000 shares at GBP0.91, worth GBP18,200, on Tuesday. Now holds 64,796 shares.

----------

Merian Chrysalis Investment Co Ltd - Independent Director Simon Holden buys 20,000 shares at 83p, worth GBP16,600, on Tuesday.

----------

Baillie Gifford Shin Nippon PLC - Chair Neil Donaldson buys 13,886 shares at 109.34p, worth GBP15,183, on Wednesday.

----------

Scottish Investment Trust PLC - Deputy Manager Martin Robertson buys 2,000 shares at GBP6.03, worth GBP12,060, on Wednesday.

----------

Templeton Emerging Markets Investment Trust PLC - Director David Graham buys 4,500 shares at GBP5.81, worth GBP26,130, on Wednesday.

----------

Fidelity Special Values PLC - Non-Executive Director Andy Irvine buys 75,000 shares at GBP1.435, worth GBP107,625, on Wednesday. Now holds 200,000 shares.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
15 Feb 2023 14:21

IN BRIEF: 4D Pharma shares cancelled from trading on London's AIM

4D Pharma PLC - Leeds-based pharmaceutical firm - Notes cancellation of its shares on AIM from Thursday, after it entered into administration in June 2022.

Read more
3 Feb 2023 15:17

TRADING UPDATES: GCP Infra hails NAV rise; Jadestone profits from oil

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2023 15:58

UK shareholder meetings calendar - next 7 days

Tuesday 10 January 
Valereum Blockchain PLCAGM
Wishbone Gold PLCAGM
Wednesday 11 January 
AB Dynamics PLCAGM
Asos PLCAGM
Edge Performance VCT PLCGM re deed of release
Hurricane Energy PLCAGM
Induction Healthcare Group PLCAGM
MetalNRG PLCGM requisitioned to remove chair and CEO from board
Synthomer PLCGM re sale of laminates business
Thursday 12 January 
JPMorgan Japanese Investment Trust PLCAGM
Friday 13 January 
eEnergy Group PLCGM re shareholder resolution to adopt the 2022 Accounts
Monday 16 January 
4D Pharma PLCGM re update on administration and suspension of trading
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
30 Dec 2022 17:21

4D Pharma seeks approval for equity fundraise to lift suspension

(Alliance News) - 4D Pharma PLC on Friday said it was seeking shareholder approval for a USD15.0 million cash raise, as it works to lift its suspension and restore its shares to trading.

Read more
16 Nov 2022 17:00

4D Pharma says trial results show Blautix eases IBS symptoms

(Alliance News) - 4D Pharma PLC said on Wednesday that its Blautix phase 2 clinical trial results showed the treatment had a positive effect on sufferers of irritable bowel syndrome

Read more
24 Aug 2022 11:44

IN BRIEF: 4D Pharma publishes pre-clinical research for autism

4D Pharma PLC - Leeds, England-based pharmaceutical company - Releases its publication of pre-clinical research on mice regarding live biotherapeutic MRx0006 for the treatment of autism spectrum disorder. Says research shows LBP MRx0006 can attenuate core behavioural deficits in a mouse model of autism, improving social deficits, repetitive and anxiety-like behaviours. "Mechanistically, MRx0006 increased in the brains of ASD mice the expression of neuropeptide hormones known to regulate social and anxiety behaviour," 4D Pharma adds.

Read more
5 Aug 2022 14:58

TRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News:

Read more
1 Jul 2022 20:05

TRADING UPDATES: Capital wins contracts; 4D pharma pauses enrolment

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Friday and not separately reported by Alliance News:

Read more
28 Jun 2022 21:23

IN BRIEF: 4D Pharma shares to be delisted from Nasdaq

4D Pharma PLC - Leeds, England-based pharmaceutical company - Says it has received written notice from the Nasdaq Stock Market that its securities will be delisted from Nasdaq. Accordingly, trading of its shares will be suspended from the opening of business on July 7. Nasdaq staff cited 4D's announcement that it had been placed into administration on Friday as raising "public interest concerns". The exchange also mentioned concerns regarding the residual equity interest of existing shareholders of listed securities.

Read more
24 Jun 2022 19:09

IN BRIEF: 4d Pharma faces uncertain future as loan repayment due

4d Pharma PLC - Leeds, England-based pharmaceutical company - Says it has "no immediate certainty" of how it will repay the USD13.9 million loan facility it has with Oxford Finance LLC.

Read more
24 Jun 2022 14:33

IN BRIEF: 4d Pharma suspends trading immediately, pending announcement

4d Pharma PLC - Leeds, England-based pharmaceutical company - Says it has ordered an immediate suspension of trading in the company's shares on AIM pending a further announcement.

Read more
24 Jun 2022 12:35

4D Pharma requests immediate suspension of its shares

(Sharecast News) - Biotherapeutics developer 4D Pharma requested an immediate suspension of trading in its shares on Friday.

Read more
21 Jun 2022 16:05

UK shareholder meetings calendar - next 7 days

Wednesday 22 June 
ASA International Group PLCAGM
Atalaya Mining PLCAGM
Bonhill Group PLCAGM
Chapel Down Group PLCAGM
Churchill China PLCAGM
Downing Renewables & Infrastructure Trust PLCGM re share issue
Ecofin US Renewables Infrastructure Trust PLCAGM
EJF Investments LtdAGM
Frenkel Topping Group PLCAGM
Good Energy Group PLCAGM
Honeycomb Investment Trust PLCAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Intelligent Ultrasound Group PLCAGM
Iofina PLCAGM
John Wood Group PLCAGM
Kingfisher PLCAGM
LXi REIT PLCGM
Menhaden PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Pennant International Group PLCAGM
Plant Health Care PLCAGM
Skillcast Group PLCAGM
Team PLCAGM
Tribal Group PLCGM re final dividend
Trident Royalties PLCAGM
Vertu Motors PLCAGM
Wentworth Resources PLCAGM
Thursday 23 June 
Avacta Group PLCAGM
Anglo Asian Mining PLCAGM
Card Factory PLCAGM
Cordiant Digital Infrastructure LtdAGM
Downing Renewables & Infrastructure Trust PLCGM re initial placing & open offer
Eight Capital Partners PLCGM re aligning 2022 bonds with 2026 bonds
GENinCode PLCAGM
Ideagen PLCGM re takeover by Hg Pooled Management Ltd
Longboat Energy PLCAGM
Oxford Nanopore Technologies PLCAGM
Puma VCT 13 PLCGM re cancellation of listing & liquidation
RBG Holdings PLCAGM
Tandem Group PLCAGM
Union Jack Oil PLCAGM
Zinnwald Lithium PLCAGM
Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
Tuesday 28 June 
4D Pharma PLCAGM
Acceler8 Ventures PLCAGM
Airtel Africa PLCAGM
Alina Holdings PLCAGM
Aquila Energy Efficiency Trust PLCAGM
Attraqt Group PLCAGM
Bay Capital PLCAGM
Capital & Counties Properties PLCAGM
CMO Group PLCAGM
Corre Energy BVAGM
Creo Medical Group PLCAGM
Futura Medical PLCAGM
Gama Aviation PLCAGM
ICG Enterprise Trust PLCAGM
ImmuPharma PLCAGM
IQE PLCAGM
Katoro Gold PLCAGM
Rockhopper Exploration PLCAGM
Sound Energy PLCAGM
TP Group PLCAGM
UK Oil & Gas PLCAGM
Volvere PLCAGM
Zegona Communications PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
27 May 2022 10:46

4D Pharma reports progress in bladder cancer trial

(Sharecast News) - Live biotherapeutics developer 4D Pharma announced progress in the phase 2 clinical trial in bladder cancer on Friday.

Read more
27 May 2022 09:31

IN BRIEF: 4D Pharma plans to test MRx0518 in combination with Bavencio

4D Pharma PLC - Leeds, England-based pharmaceutical company - Plans to conduct a phase II study to assess the safety of MRx0518 in combination with Bavencio. Says the study will be conducted in patients with unresectable locally advanced or metastatic urothelial carcinoma, a type of bladder cancer. Says previous data about MRx0518 supports the potential of this combination to "significantly enhance and improve" outcomes for patients, beyond treatment with Bavencio alone. Bavencio is an antibody medication for the treatment of urothelial carcinoma.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.